by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersCitra100mg

All Warning Letters

Citra100mg

Warning LetterOpen

Citra100mg, United StatesIssued Mar 4, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations3

Issue DateMar 4, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Citra100mg
Location: Citra100mg, United States
FEI Number: N/A
Country: United States
Issue Date: March 04, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Unapproved New Drugs/Misbranded

Citra100mg FDA Warning Letter, March 4, 2026